FDA Warning Letter — Medlife Pharmacy And Compounding

Case 607417 — FEI 3014332926

The FDA took a Warning Letter action against Medlife Pharmacy And Compounding on Apr 30, 2020 (Irvine, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action details

Facility
Medlife Pharmacy And Compounding
Date
Apr 30, 2020
Fiscal Year
2020
Product Type
Drugs
Center
CDER
Location
Irvine, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.